National Biological Corp., headquartered in the United States, is a leading player in the biotechnology industry, specialising in the development and manufacturing of high-quality biological products. Founded in 1985, the company has established a strong presence across major operational regions, including North America and Europe. With a focus on innovative solutions, National Biological Corp. offers a diverse range of products, including diagnostic reagents and laboratory supplies, distinguished by their reliability and precision. The company has achieved significant milestones, such as expanding its product line and enhancing its research capabilities, solidifying its market position as a trusted provider in the life sciences sector. National Biological Corp. continues to drive advancements in biotechnology, contributing to the evolution of scientific research and healthcare.
How does National Biological Corp.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
National Biological Corp.'s score of 23 is lower than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
National Biological Corp., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that National Biological Corp. may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As such, the company appears to be in the early stages of addressing its climate impact within the industry context.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
National Biological Corp. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.